Find More Contacts for Cepheid
Protected Content
Security Architect
Non-Management, Executive Information Technology, Operations
2 emails found 3 phone numbers found
View contacts for Cepheid to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 4085416439

Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform

sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Lists Featuring This Company

United States Companies (Top 10K)
9,609 Number of Organizations • $2.9T Total Funding Amount • 95,452 Number of Investors
Companies With More Than 50 Employees (Top 10K)
10,000 Number of Organizations • $4.5T Total Funding Amount • 98,028 Number of Investors
Biotechnology Acquired Companies
3,479 Number of Organizations • $132.6B Total Funding Amount • 6,544 Number of Investors
Companies With More Than 1000 Employees (Top 10K)
9,377 Number of Organizations • $4.4T Total Funding Amount • 29,827 Number of Investors
Cepheid was acquired by Danaher for $4B on Sep 6, 2016.

Frequently Asked Questions

Where is Cepheid's headquarters? Cepheid is located in Sunnyvale, California, United States.Who invested in Cepheid? Cepheid has 5 investors including U.S. Department of Defense and U.S. Department of Health & Human Services.How much funding has Cepheid raised to date? Cepheid has raised .When was the last funding round for Cepheid? Cepheid closed its last funding round on Oct 22, 2021 from a Grant round.Who are Cepheid's competitors? Alternatives and possible competitors to Cepheid may include IlluminaBillionToOne, and NeoGenomics.